1 option
Daptomycin for methicillin-resistant and methicillin-sensitive staphylococcus aureus infection : a review of clinical effectiveness, cost-effectiveness and guidelines / Canadian Agency for Drugs and Technologies in Health.
- Format:
- Book
- Author/Creator:
- Canadian Agency for Drugs and Technologies in Health, author.
- Series:
- Rapid response report (Canadian Agency for Drugs and Technologies in Health)
- Rapid response report
- Language:
- English
- Subjects (All):
- Staphylococcus aureus infections--Chemotherapy.
- Staphylococcus aureus infections.
- Methicillin resistance.
- Daptomycin--therapeutic use.
- Staphylococcal Infections--drug therapy.
- Methicillin-Resistant Staphylococcus aureus.
- Medical Subjects:
- Daptomycin--therapeutic use.
- Staphylococcal Infections--drug therapy.
- Methicillin-Resistant Staphylococcus aureus.
- Physical Description:
- 1 online resource (40 pages) : illustrations.
- Place of Publication:
- Ottawa : Canadian Agency for Drugs and Technologies in Health, 2016.
- Notes:
- Description based on: online resource; title from PDF information screen (NCBI, viewed October 25, 2022).
- "21 January 2016".
- Includes bibliographical references (pages 16-18).
- OCLC:
- 946888699
- Publisher Number:
- 10049148 CaOOCEL (Public Documents)
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.